Chronic Hand Eczema Studies Show Condition is Common, Burdensome
LEO Pharma presented data from 2 of the largest multinational real-world studies on the prevalence, severity and treatment of chronic hand eczema at the European Society of Contact Dermatitis congress.
Now Trending: Simplified HIV Treatments, Lesser-Known Social Detriments of Health
Check out this recap of articles published on our sister sites during the past week.
Small Doses: September 2 to September 6
Check out a recap of important pharmacy news you might have missed this week, dispensed in small doses.
Abbott’s OTC Lingo CGM for Wellness Now Available
Lingo offers users a real-time glucose graph, a metric to track glucose spikes, food and activity logging, personal recommendations, and challenges to motivate healthy behaviors.
Community Pharmacist-Led Intervention for Victims of Domestic Abuse, Suicidal Ideation
Researchers analyzed a co-developed pharmacy-based intervention for individuals who have experienced domestic abuse or suicidal ideation.
FDA Approves Nymalize in Prefilled ENFit Syringes
Nymalize is an effective alternative to capsule extraction for adult patients with subarachnoid hemorrhage who are unable to swallow capsules.
FDA Roundup: Novavax COVID-19 Vaccine, First Digital Therapeutic for GAD
Check out important updates from the FDA for the week of September 2.
NCPA Calls on CMS to Establish PBM Protection for Independent Pharmacies
As Medicare open enrollment begins, the NCPA is urging CMS to facilitate appropriate PBM contracting for pharmacies in the upcoming plan year.
Pharmacist-Led Interventions Improve Hypertension Outcomes in Remote Program
Findings were presented at the American Heart Association's Hypertension Scientific Sessions in Chicago, Illinois.
C Difficile Treatment Shows Positive Results in Phase 2 Study
CRS3123 is a novel, small molecule, antibiotic drug candidate that selectively inhibits 1 form of the bacterial methionyl-tRNA synthetase enzyme and is not affected by resistance to any existing classes of antibiotics.
Major Drug Distributors to Pay $300 Million in Opioid Epidemic Settlements
McKesson, Cardinal Health, and Cencora will share the settlement payment, resolving claims that the companies were significantly involved in fueling the US opioid epidemic.
FDA Clears First Digital Therapeutic for Treatment of Generalized Anxiety Disorder
DaylightRX from Big Health is a digital formulation of cognitive behavioral therapy and is available by prescription only.
FDA Clears New Disposable Insulin Patch Pump for Patients With T1D and T2D
Embecta’s new patch pump offers a larger insulin reservoir to better accommodate for the needs of patients with type 2 diabetes (T2D).
Digital Therapeutic Shows Significant Reduction in Episodic Migraine
Click Therapeutics announced that CT-132 met its primary endpoint in the phase 3 ReMMi-D trial.
Q&A: Turning Old Technology into Something New for Pharmaceutical Storage
Dana Krug, Senior Vice President of Cold Chain Fulfillment at Phononic, explained the current state of his company’s cooling technology and the common trends of temperature control throughout the industry.
Familial Chylomicronemia Syndrome Treatment Shows Positive Results in Phase 3 Trial
Results from the PALISADE study were published in The New England Journal of Medicine.
After Initial Stumbles, Tolebrutinib Achieves Primary Endpoint in Phase 3 nrSPMS Trial
Results from HERCULES will form the basis for future discussions with global regulatory authorities, according to Sanofi.
FDA Approves Updated Novavax COVID-19 Vaccine
The protein-based vaccine includes a monovalent component corresponding to the Omicron variant JN.1 strain.
Immunization Roundup: Updated COVID-19 Vaccines, Mpox Approval, and More
Catch up on important immunization news from the month of August.
Weekend ICYMI: August 26 to August 30
In case you missed it, this week we had news about COVID-19 and the upcoming respiratory virus season, advancements in clinical trials for ASCVD, the first OTC birth control, and more.
Small Doses: August 26 to August 30
Q&A: How Health Care Providers Can Help Increase COVID-19 Vaccine Uptake
Chijioke Bennett, executive director of clinical development at Novavax, discusses how health care providers can increase awareness around the importance of COVID-19 vaccines.
FDA Approves Expanded Use of ACAM2000 Vaccine for Mpox Amid Public Health Emergency
Emergent BioSolutions has announced that it will donate 50,000 doses of ACAM2000 for potential deployment across affected areas in Central Africa.
Diabetes Roundup: FDA Clears Omnipod 5, Tirzepatide Demonstrates Trial Success, and More
Catch up on important diabetes news from the month of August.
FDA Roundup: Agency Highlights from August 2024
Checkout these important FDA updates from the month of August 2024.
Roflumilast Cream Shows Durable Safety, Efficacy in Children with Atopic Dermatitis
Results from the INTEGUMENT-OLE phase 3 trial showed the therapy was also well-tolerated, with no new safety signals observed during treatment of up to 56 weeks.
Q&A: Opill Ushers in New Era of Access to Birth Control
Stephanie Sober, MD, MSHP, investigator on the pivotal research that supported the prescription-to-OTC switch of Opill, shares insights on how the medicine is reshaping the reproductive landscape.
Psilocybin Mushrooms: A Journey from Ancient Traditions to Modern Clinical Use
As research continues to uncover the potential benefits of psilocybin, pharmacists and other clinicians have an essential role in bridging ancient wisdom with contemporary science.
Investigational Acute Pain Therapy to be Evaluated in Pivotal Phase 3 Trials
Tris Pharma will examine the efficacy and safety of cebranopadol in the ALLEVIATE-1 and ALLEVIATE-2 studies.
ICYMI: Drug Topics July/August 2024 Issue
Don’t miss out on the latest pharmacy insights in the Drug Topics July/August issue.
